March 8, 2024

Hidradenitis suppurativa leads to a substantial decrease in work ability and productivity, according to the results of a prospective study. Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with lesions in intertriginous areas and areas with apocrine glands. Retrospective studies have described the disease burden as chronic and debilitating. A prospective, multicenter, epidemiological, noninterventional...

In the IDEA trial, postmenopausal patients aged 50–69 years with pT1N0 unifocal invasive breast cancer who did not receive radiotherapy achieved a high level of disease control after 5 years. For over three decades, radiotherapy has been an essential part of the treatment following breast-conserving surgery (BCS) for patients with early-stage breast cancer. Recent studies...

Ruxolitinib cream monotherapy rapidly and significantly improves signs and symptoms of atopic dermatitis such as inflammatory skin lesions and itch reduction, in all areas of the body, according to pooled results of two phase 3 studies. Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by intense itching and redness, particularly in visible areas...

By Roger Mosley The real-life effectiveness and safety of dupilumab in treating moderate-to-severe atopic dermatitis was explored in a recent retrospective study on patients with various comorbidities, including malignancies. The drug may be safe and effective across a diverse patient demographic, reinforcing its potential as a versatile treatment option in clinical practice. Dupilumab proved effective...

A new prospective study reports that omalizumab effectively manages hives in patients with chronic urticaria. Chronic urticaria impacts 0.5–1% of adults and is marked by the appearance of itchy hives with or without angioedema lasting at least 6 weeks. Physical stimuli such as pressure, cold, heat, and vibration induce hives in 20% of patients, categorized...